145 related articles for article (PubMed ID: 35440375)
1. Testing key messages about extending cervical screening intervals.
A V Marlow L; Nemec M; Barnes J; Waller J
Patient Educ Couns; 2022 Aug; 105(8):2757-2762. PubMed ID: 35440375
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of extending HPV-based cervical screening intervals from 3 to 5 years: an interview study with women in England.
Nemec M; Waller J; Barnes J; Marlow LAV
BMJ Open; 2022 May; 12(5):e058635. PubMed ID: 35508345
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
5. Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study.
Hill E; Nemec M; Marlow L; Sherman SM; Waller J
J Med Screen; 2021 Sep; 28(3):333-340. PubMed ID: 33175638
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.
Tatar O; Thompson E; Naz A; Perez S; Shapiro GK; Wade K; Zimet G; Gilca V; Janda M; Kahn J; Daley E; Rosberger Z
Prev Med; 2018 Nov; 116():40-50. PubMed ID: 30172799
[TBL] [Abstract][Full Text] [Related]
7. Change in Provider Beliefs Regarding Cervical Cancer Screening Intervals After an Educational Intervention.
Benard VB; Greek A; Roland KB; Hawkins NA; Lin L; Saraiya M
J Womens Health (Larchmt); 2016 May; 25(5):422-7. PubMed ID: 27096534
[TBL] [Abstract][Full Text] [Related]
8. "A lot can happen in five years": Women's attitudes to extending cervical screening intervals.
Kola-Palmer S; Rogers M; Halliday A; Rickford R
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13655. PubMed ID: 35838304
[TBL] [Abstract][Full Text] [Related]
9. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.
Rebolj M; Cuschieri K; Mathews CS; Pesola F; Denton K; Kitchener H;
BMJ; 2022 May; 377():e068776. PubMed ID: 35640960
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
11. Primary HPV DNA based cervical cancer screening at 25 years: Views of young Australian women aged 16-28 years.
Jayasinghe Y; Rangiah C; Gorelik A; Ogilvie G; Wark JD; Hartley S; Garland SM
J Clin Virol; 2016 Mar; 76 Suppl 1():S74-S80. PubMed ID: 26589584
[TBL] [Abstract][Full Text] [Related]
12. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
[TBL] [Abstract][Full Text] [Related]
13. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
[TBL] [Abstract][Full Text] [Related]
14. Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
Rohner E; McGuire FH; Liu Y; Li Q; Miele K; Desai SA; Schmitt JW; Knittel A; Nelson JAE; Edelman C; Sivaraman V; Baker A; Romocki LS; Rahangdale L; Smith JS
J Womens Health (Larchmt); 2020 Jul; 29(7):971-979. PubMed ID: 32212991
[No Abstract] [Full Text] [Related]
15. By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
Castanon A; Landy R; Sasieni P
J Med Screen; 2017 Jun; 24(2):110-112. PubMed ID: 27363972
[TBL] [Abstract][Full Text] [Related]
16. Women's acceptability of and experience with primary human papillomavirus testing for cervix screening: HPV FOCAL trial cross-sectional online survey results.
Smith LW; Racey CS; Gondara L; Krajden M; Lee M; Martin RE; Stuart G; Peacock S; Coldman AJ; Franco EL; van Niekerk D; Ogilvie GS
BMJ Open; 2021 Oct; 11(10):e052084. PubMed ID: 34620663
[TBL] [Abstract][Full Text] [Related]
17. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
18. Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
Tatar O; Wade K; McBride E; Thompson E; Head KJ; Perez S; Shapiro GK; Waller J; Zimet G; Rosberger Z
J Womens Health (Larchmt); 2020 Mar; 29(3):390-405. PubMed ID: 31479381
[No Abstract] [Full Text] [Related]
19. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta.
Scarinci IC; Litton AG; Garcés-Palacio IC; Partridge EE; Castle PE
Womens Health Issues; 2013; 23(2):e123-30. PubMed ID: 23410619
[TBL] [Abstract][Full Text] [Related]
20. Psychological Impact of Primary Screening (PIPS) for HPV: a protocol for a cross-sectional evaluation within the NHS cervical screening programme.
McBride E; Marlow L; Forster AS; Moss S; Myles J; Kitchener H; Patnick J; Waller J
BMJ Open; 2016 Dec; 6(12):e014356. PubMed ID: 28011816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
